About Arteriocyte
Arteriocyte is a company based in Hopkinton (United States) founded in 2007 by Donald Brown.. Arteriocyte has raised $15.11 million across 6 funding rounds from investors including HHS, Cleveland Clinic Innovations and DW Management Services. Arteriocyte offers products and services including Magellan, Influx, and InQu. Arteriocyte operates in a competitive market with competitors including Hemotune, Medcura, ExThera Medical, Lindis Blood Care and CytoPherx, among others.
- Headquarter Hopkinton, United States
- Founders Donald Brown
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Arteriocyte
Arteriocyte offers a comprehensive portfolio of products and services, including Magellan, Influx, and InQu. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
System for creating platelet-rich plasma and bone marrow therapies.
Allograft products for bone grafting and healing applications.
Biosynthetic bone graft for faster fusion in medical procedures.
Funding Insights of Arteriocyte
Arteriocyte has successfully raised a total of $15.11M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $2.48 million completed in March 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $2.5M
-
First Round
First Round
(01 Nov 2007)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2011 | Amount | Grant - Arteriocyte | Valuation |
investors |
|
| Mar, 2011 | Amount | Debt – Convertible - Arteriocyte | Valuation |
investors |
|
| Jul, 2009 | Amount | Series A - Arteriocyte | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Arteriocyte
Arteriocyte has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Cleveland Clinic Innovations and DW Management Services. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health tech startups are supported through incubation services.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Arteriocyte
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Arteriocyte
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Arteriocyte Comparisons
Competitors of Arteriocyte
Arteriocyte operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemotune, Medcura, ExThera Medical, Lindis Blood Care and CytoPherx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of a device for blood purification
|
|
| domain | founded_year | HQ Location |
Developer of the device for controlling bleeding
|
|
| domain | founded_year | HQ Location |
Medical devices for the rapid treatment of bloodstream infections and pathogen-reduction in blood banking
|
|
| domain | founded_year | HQ Location |
Innovative solutions for safer blood transfusions are developed.
|
|
| domain | founded_year | HQ Location |
Cytopheresis systems for inflammatory conditions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Arteriocyte
Frequently Asked Questions about Arteriocyte
When was Arteriocyte founded?
Arteriocyte was founded in 2007.
Where is Arteriocyte located?
Arteriocyte is headquartered in Hopkinton, United States. It is registered at Hopkinton, Massachusetts, United States.
Is Arteriocyte a funded company?
Arteriocyte is a funded company, having raised a total of $15.11M across 6 funding rounds to date. The company's 1st funding round was a Series A of $100K, raised on Nov 01, 2007.
What does Arteriocyte do?
Arteriocyte Medical Systems, is a medical device company that develops products to accelerate healing in patients. Its lead product, Magellan Autologous Platelet Separator provides surgeons the ability to fractionate peripheral blood, or a mixture of blood and aspirated bone marrow from a patient. It also produces Demineralized Bone Matrix in the form of powder - MAR0Match or in the form of gel - MAR0Fuse. Other products include Magellan PRP to prepare Platelet Rich Plasma, and MAR0Max kit that provides the surgeon tools needed to Aspirate, Concentrate and Deliver a mixture of whole blood and bone marrow.
Who are the top competitors of Arteriocyte?
Arteriocyte's top competitors include Medcura, ExThera Medical and Lindis Blood Care.
What products or services does Arteriocyte offer?
Arteriocyte offers Magellan, Influx, and InQu.
Who are Arteriocyte's investors?
Arteriocyte has 3 investors. Key investors include HHS, Cleveland Clinic Innovations, and DW Management Services.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.